Predictions
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€45.63
18.08.19
18.08.19
-
04.11.21
04.11.21
5.23%
03.04.21
03.04.21
Coca-Cola Co.
Start price
Target price
Perf. (%)
€41.33
08.02.21
08.02.21
€45.00
08.02.22
08.02.22
10.74%
29.03.21
29.03.21
Could be worthwhile Investment >10% per year
Some uniques
Top 10 in its market
Known brand
Coca-Cola Co.
Start price
Target price
Perf. (%)
€42.48
19.03.21
19.03.21
-
19.03.22
19.03.22
0.99%
22.03.21
22.03.21
Could be worthwhile Investment >10% per year
Coca-Cola Co.
Start price
Target price
Perf. (%)
€43.17
17.03.21
17.03.21
€52.00
-0.61%
20.03.21
20.03.21
Market Leader or Top 3
Could be worthwhile Investment >10% per year
Well known brand
Coca-Cola Co.
Start price
Target price
Perf. (%)
€44.16
19.12.20
19.12.20
€47.00
-2.50%
13.03.21
13.03.21
Small Risks for its business
Market Leader or Top 3
Well known brand
Undervalued
Coca-Cola Co.
Start price
Target price
Perf. (%)
€40.05
21.08.20
21.08.20
€61.00
04.11.21
04.11.21
5.12%
15.02.21
15.02.21
Market Leader or Top 3
Could be worthwhile Investment >10% per year
Well known brand
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€35.13
15.05.20
15.05.20
€60.00
04.11.21
04.11.21
16.55%
04.02.21
04.02.21
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€38.53
27.05.20
27.05.20
€55.00
04.11.21
04.11.21
4.20%
12.01.21
12.01.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Known brand
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€29.51
10.09.20
10.09.20
-
29.10.20
29.10.20
-2.56%
29.10.20
29.10.20
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€48.39
20.02.20
20.02.20
€52.40
21.10.20
21.10.20
-34.22%
21.10.20
21.10.20
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€116.00
20.02.20
20.02.20
€150.00
21.10.20
21.10.20
4.76%
21.10.20
21.10.20
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€111.82
03.08.20
03.08.20
€125.00
20.10.20
20.10.20
7.87%
20.10.20
20.10.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating